John Hall

SVP, EMEA & APAC, CluePoints


Achieving Successful Decentralized Trials by Leveraging RBQM and Centralized Monitoring Oversight

April 07, 2022

As market factors drive the rapid growth of decentralized clinical trials, organizations should embrace risk-based quality management to evaluate the new dimensions of risk and ensure effective oversight of disparate data sources, writes John Hall.